MLS Capital Fund II LP - May 29, 2023 Form 3 Insider Report for GreenLight Biosciences Holdings, PBC (GRNA)

Role: Other*
Signature: MLS Capital Fund II, L.P. By: MLSCF II (GP) (Labuan), LLP Its: General Partner By: /s/ Ganesh Kishore Title: Manager
Stock symbol: GRNA
Transactions as of: May 29, 2023
Transactions value $: $0
Form type: 3
Date filed: 7/26/2023, 08:34 PM
Next filing: Jul 26, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	GRNA	Common Stock, par value $0.0001 per share						5.82M	May 29, 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

The Reporting Person filed a Statement on Schedule 13D with the Securities and Exchange Commission on June 6, 2023, with respect to the shares reported herein. The Reporting Person may be deemed to be members of a "group" (within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934 of persons that, in the aggregate, beneficially owned more than 10% of the Issuer's Common Stock. The filing of this Form 3 shall not be construed as an admission that the Reporting Person was a beneficial owner of more than 10% of any class of securities of the Issuer for purposes of Section 16(a) of the Securities Exchange Act of 1934 or for any other purpose.